ZoomInfo Technologies (GTM) has announced several new partnerships and integrations, most notably a deeper integration with Salesforce’s Hunter agent, alongside rollouts with n8n, ClickUp, and expanded GTM.AI capabilities via Workbounce. These moves aim to embed ZoomInfo's data platform deeper into customer workflows, which could improve contract stickiness and data usage, vital for the company's revenue stability after a recent downtrend. While analysts project a revenue decline of 1.3% per year, earnings are expected to significantly improve from a loss of US$541.0 million to a profit of US$391.8 million by 2029.

TCL Electronics Holdings Limited has renewed its multi-year licensing agreement with Adeia Inc. for access to Adeia’s media intellectual property portfolio. This renewal continues the existing relationship between the two companies, with Adeia's IP covering technologies for content discovery, personalization, and streaming on smart TVs. The financial terms of the deal were not disclosed.

This page provides an overview of Draganfly Inc. (DPRO) stock, including its current price, news, and historical performance. The "All News" section lists recent articles related to Draganfly and other companies, covering earnings, strategic investments, and market analysis. The "Performance overview" section details Draganfly's trailing total returns compared to the S&P/TSX Composite index.

Argus has raised its target price for Harmonic Inc. (HLIT) to $11.00, citing the company's engagement in broadband access solutions for high-speed internet and versatile video delivery. The current price for HLIT is $10.09. The report was published on October 21, 2026.

Integrated Advisors Network LLC significantly reduced its stake in Microchip Technology Incorporated, selling 31,405 shares, which represents a 74.2% cut. Despite this, Microchip Technology exceeded analyst expectations with its recent quarterly earnings and revenue, reporting $0.76 EPS on $1.48 billion, and also declared a quarterly dividend of $0.455. The stock currently holds a "Moderate Buy" consensus rating from analysts, with an average price target of $97.71, though shares opened down 3.4% at $74.52.

The Pictet AI Enhanced US Equity ETF (PQUS) is an actively managed ETF that uses artificial intelligence to invest primarily in U.S. company equity securities. Its top holdings include major tech companies like NVIDIA, Apple, and Microsoft, which collectively represent a significant portion of its assets. The fund's sector allocation is heavily weighted towards technology, making up over 42% of its portfolio.

Flywire Corporation (NASDAQ:FLYW) has a consensus "Hold" rating from analysts, with an average 12-month price target of $20.31. Despite a 27.2% year-over-year revenue increase to $163.8 million, the company missed adjusted earnings expectations, and insiders sold $11.2 million worth of stock in the last 90 days. Flywire shares opened at $19.15, giving the company a market capitalization of $2.33 billion.

Crossmark Global Holdings Inc. reduced its stake in Flex Ltd. by 28.4% in the third quarter, selling 32,561 shares and retaining 82,192 shares valued at $9.04 million. Flex is navigating a planned spin-off of its Axiom business and recently acquired EPC Power for $4.4 billion, which introduces execution and financial risks, including a $2 billion preferred investment obligation and $1.1 billion in bridge financing. Flex shares opened down 11.1% amid broader weakness in AI and data-center infrastructure stocks, though analysts maintain a "Moderate Buy" consensus with an average price target of $119.67.

Argus has raised its target price for Paycom Software, Inc. (PAYC) to $289.00, up from its previous target. The report, published on October 21, 2026, highlights Paycom's role as a human capital management software-as-a-service provider offering solutions for payroll, talent acquisition, HR management, and time and labor. The current stock price for PAYC is $272.61.

Charles River Laboratories International, Inc. announced a Research Collaboration Agreement with the U.S. Food and Drug Administration (FDA) and Labcorp. This collaboration aims to develop sensitive screening tools to quantify and rank the abuse potential of new drugs, including abuse-deterrent formulations (ADFs) and emerging drugs of abuse. The goal is to enhance objective, standardized metrics for quantifying abuse potential in preclinical models to inform regulatory assessments under the Controlled Substances Act.